Stock & Company Details
Adc Therapeutics SA $ADCT
Price:
N/A
N/A
141M
$183M
52 Week High:
N/A
10 Day Average Volume:
N/A
-1.79
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
ADCT technical indicators
Latest Adc Therapeutics SA (ADCT) indicator readings as of 2026-11-19.
ADCT's 14-day RSI is 43.2, in neutral territory. ADX reads 19.3, indicating a range-bound market rather than a trend. MACD (12, 26, 9) is -0.03, below the zero line.
Overview
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212.
Finance Bot
Ask your questions
Start by typing a question below.